Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-99.91% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
RKDA · Mar 31, 2026
Arcadia Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-223990General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
-8.33% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
76.36% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
36.36% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-70.82% · CORE · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.36% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History19 statesSelf-history eligible
Dec 31, 20210/7 normalizedLevel 3Mar 31, 20220/7 normalizedLevel 3Jun 30, 20220/7 normalizedLevel 3Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20236/8 normalizedLevel 3Dec 31, 20237/8 normalizedLevel 3Mar 31, 20247/8 normalizedLevel 3Jun 30, 20247/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -97.55%
- Current
- -99.91%
- Delta
- -2.36%
- Previous
- -3.71%
- Current
- -8.33%
- Delta
- -4.63%
- Previous
- 24.95%
- Current
- 76.36%
- Delta
- 51.42%
- Previous
- 36.23%
- Current
- 36.36%
- Delta
- 0.13%
- Previous
- -51.46%
- Current
- -70.82%
- Delta
- -19.36%
- Previous
- 4.82%
- Current
- 1.36%
- Delta
- -3.45%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · RKDA Fundamental State →Has State · Arcadia Biosciences, Inc. →Transitioned To · RKDA historical state 2025-12-31 →Transitioned To · RKDA CASH_GENERATION_DECREASED →Transitioned To · RKDA GROWTH_DECREASED →Transitioned To · RKDA INVENTORY_PRESSURE_INCREASED →Transitioned To · RKDA MARGIN_INCREASED →Transitioned To · RKDA PROFITABILITY_DECREASED →Transitioned To · RKDA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.